Crystallex International Corp. (USA) 

(Public, AMEX:KRY)   Watch this stock   
Find more results for KRY
Nov 11, 2009
Q3 2009 Crystallex International Earnings Release
More events from AOL Finance »    

Key stats and ratios

Q2 (Jun '09) 2008
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -6.52% -6.04%
Return on average equity -9.36% -78.31%
Employees 177 -

Address

18 King Street East Suite 1210
Toronto, ON M5C 1C4
Canada
+1-416-2032448 (Phone)
+1-416-2030099 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance

Crystallex International Corp. (USA) discussed on blogs

Ranking All U.S. Stocks by Weekly Performance - NASD100.com ... - Investor's Resources - NASD100.com - Daily Stock Rankings - 8 hours ago

Crystallex International Corp. (USA) discussions

  View all discussions »

Description

Crystallex International Corporation (Crystallex) is a Canada-based gold producer. The Company has operations and exploration properties in Venezuela. Its principal asset is the Las Cristinas project in Bolivar State. During the year ended December 31, 2008, gold production in Venezuela was 17,885 ounces. Crystallex plans to commence gold production at Las Cristinas at its base case level of 20,000 tons per day. Its other properties included Tomi and La Victoria mines. Crystallex owns 100% of the Tomi concession, which is located approximately 16 kilometer northeast of the town of El Callao in the El Callao District, Bolivar State, Venezuela. There are four adjoining deposits on the concession, namely Charlie Richards, Mackenzie, Milagrito and Fosforito. In September 2008, the Company ceased mining at the Tomi and La Victoria mines.

Officers and directors

Robert Arthur Fung
Executive Chairman of the Board, Chief Executive Officer
Bio & Compensation - Reuters
Robert Crombie Ph.D.
President
Bio & Compensation - Reuters
Hemdat Sawh
Chief Financial Officer
Bio & Compensation - Reuters
William A. Faust
Chief Operating Officer, Senior Vice President
Bio & Compensation - Reuters
A. Richard Marshall
Vice President - Investor Relations
Bio & Compensation - Reuters
Gordon M. Thompson
Director
Bio & Compensation - Reuters
Marc J. Oppenheimer
Independent Director
Bio & Compensation - Reuters
Harry J. Near
Independent Director
Bio & Compensation - Reuters
Armando F. Zullo
Independent Director
Bio & Compensation - Reuters
C. William Longden
Independent Director
Bio & Compensation - Reuters